Back to search

Ojas Immune Limited

15556809

active
ltd
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

6-7 Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP
Incorporated 12/03/2024

Compliance

Last accounts

31/03/2026

micro entity

Next accounts due

31/12/2027

On track

Confirmation statement

Last: 11/03/2026

Due 25/03/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Subhankar Mukhopadhyay

director · Since 12/03/2024

SCIENTIST/SENIOR UNIVERSITY LECTURER

INDIAN · UNITED KINGDOM · Age 52

Dr. Aroul Selvam Ramadass

director · Since 12/03/2024

DIRECTOR

BRITISH · UNITED KINGDOM · Age 50

Also on 2 other boards

Mr Jack Frederick Bowyer

director · Since 22/05/2025

DIRECTOR

BRITISH · UNITED KINGDOM · Age 61

Subhankar Mukhopadhyay

director · Since 12/03/2024

Indian · United Kingdom · Age 52

Aroul Selvam Ramadass

director · Since 12/03/2024

British · United Kingdom · Age 50

Jack Frederick Bowyer

director · Since 22/05/2025

British · United Kingdom · Age 61

Persons with Significant Control

Dr Subhankar Mukhopadhyay

25–50% shares

Indian · United Kingdom · Age 52

6-7 Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP

Notified 12/03/2024

Dr. Aroul Selvam Ramadass

25–50% shares

British · United Kingdom · Age 50

6-7 Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP

Notified 12/03/2024

Change History

status → active
2026-08-23

Active

type → ltd
2026-08-23

Private Limited Company

address line1 → 6-7 Citibase, New Barclay House
2026-08-23

6-7 CITIBASE, NEW BARCLAY HOUSE

post town → Oxford
2026-08-23

OXFORD

officer appointed → BOWYER, Jack Frederick
2026-08-23
officer appointed → MUKHOPADHYAY, Subhankar, Dr
2026-08-23
officer appointed → RAMADASS, Aroul Selvam, Dr.
2026-08-23

CompanyRankvs 650+ SIC 72110 peers
71

Financial strength84th percentile among SIC peers · 21/25
Employees77th percentile among SIC peers · 12/15
LiquidityCurrent ratio 9.13× · 20/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2026

Net Worth

£193k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£187k

Working capital

Current Assets

£209k

Current Liabilities

£23k

Fixed Assets

£7k

3avg. employees+3

Balance Sheet

Assets less current liabilities£193k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20269.13+£205k
20250.17—

Derived from filed accounts. Not audited figures.